Research on the ethnic diversity of human leukocyte antigen (HLA) and genetic polymorphisms in ACE-2 should be expanded, which is the probable cause of differences in the occurrence of cutaneous manifestations of COVID-19 depending on the geographical area where the patient lives and his or her race. Here, ACE2 is linked to COVID-19.